
Lateral lumbar interbody fusion using a cellular allogeneic bone matrix in the treatment of symptomatic degenerative lumbar disc disease and lumbar spinal instability
Author(s) -
William Tally,
H. Thomas Temple,
J. Kenneth Burkus
Publication year - 2021
Publication title -
journal of spine surgery
Language(s) - English
Resource type - Journals
eISSN - 2414-469X
pISSN - 2414-4630
DOI - 10.21037/jss-21-28
Subject(s) - medicine , oswestry disability index , lumbar , visual analogue scale , radiography , spinal fusion , surgery , degenerative disc disease , degenerative disease , clinical significance , fixation (population genetics) , low back pain , lumbar vertebrae , demineralized bone matrix , radiology , central nervous system disease , dbm , pathology , population , amplifier , alternative medicine , cmos , electronic engineering , engineering , environmental health
Cellular allogeneic bone grafts are used as a biologic adjuvant in lumbar spinal fusions. The clinical use of a minimally invasive extreme lateral approach to the lumbar spine has been widely adopted; however, there are few clinical studies that have documented the clinical and radiographic outcomes associated with the use of cellular allografts as an adjunct to fusion in this advanced surgical approach.